rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Alan G. Dunn

Director

Company insider

Files Form 4 as: Director, Natural Alternatives International.

In numbers

Trades disclosed
29
Buys
0
Sells
2
Bought
$0
Sold
$131K
Companies
1
Companies where not an officer
1
First trade
28 Apr 2006
Last trade
6 Mar 2026
Last filed
10 Mar 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NAII Natural Alternatives InternationalDirector · Pharmaceuticals · last 6 Mar 20260 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
6 Mar 2026filed 10 Mar 2026NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—8,000 at $0.00filing
6 Mar 2026filed 10 Mar 2026NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—8,000 at $0.00filing
7 Mar 2025filed 11 Mar 2025NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—8,000 at $0.00filing
8 Mar 2024filed 15 Mar 2024NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—8,000 at $0.00filing
7 Mar 2023filed 9 Mar 2023NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—7,000 at $0.00filing
4 Mar 2022filed 8 Mar 2022NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—7,000 at $0.00filing
16 Mar 2021filed 18 Mar 2021NAII Natural Alternatives Internationaloption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,000 at $0.00filing
16 Mar 2021filed 18 Mar 2021NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code M$35K10,000 at $3.52filing
16 Mar 2021filed 18 Mar 2021NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Sold$35K2,117 at $16.63filing
15 Mar 2021filed 18 Mar 2021NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—4,000 at $0.00filing
17 Apr 2020filed 27 Apr 2020NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code J—15,000 at $0.00filing
1 Apr 2020filed 2 Apr 2020NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—15,000 at $0.00filing
15 Mar 2019filed 19 Mar 2019NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—10,000 at $0.00filing
17 May 2018filed 21 May 2018NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Sold$96K9,000 at $10.68filing
19 Mar 2018filed 23 Mar 2018NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—10,000 at $0.00filing
28 Mar 2017filed 30 Mar 2017NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—10,000 at $0.00filing
23 Mar 2016filed 28 Mar 2016NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—10,000 at $0.00filing
19 Mar 2015filed 23 Mar 2015NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—5,000 at $0.00filing
7 Mar 2014filed 11 Mar 2014NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—5,000 at $0.00filing
24 Jun 2013filed 26 Jun 2013NAII Natural Alternatives InternationalPharmaceuticalsSEC FORM 4 Code A—4,500 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Mark A. LedouxCEO/Chairman · CEO/Chairman at Natural Alternatives International, filing Form 4 there in the last year
Kenneth WolfPresident, COO, & Sec. · President, COO, & Sec. at Natural Alternatives International, filing Form 4 there in the last year
Guru RamanathanDirector · Director at Natural Alternatives International, filing Form 4 there in the last year
Michael E. FortinChief Financial Officer · Chief Financial Officer at Natural Alternatives International, filing Form 4 there in the last year
Laura Kay MatherlyDirector · Director at Natural Alternatives International, filing Form 4 there in the last year